Su Min, Chen Hongqiu, Wei Chaohe, Chen Ning, Wu Wei
Faculty of Basic Medicine, Guilin Medical University, Guilin 541004, PR China.
Department of Pathology, Guigang City People's Hospital, Guigang, Guangxi 537100, PR China.
Int Immunopharmacol. 2014 Oct;22(2):492-7. doi: 10.1016/j.intimp.2014.07.034. Epub 2014 Aug 10.
Pathologically, liver injury can result from sustained trauma to hepatocytes, including acute damage. Thus, attenuation of hepatocellular lesion may help improve liver functions. The purpose of this study was to explore the potential advantages of vitamin C (VC) intake on acutely intralesional liver in carbon tetrachloride (CCl4)-exposed mice. Here our data showed that VC supplementation contributed to ameliorated vital signs of CCl4-lesioned mice, resulting in dose-dependent reduction of hepatomegaly. VC lowered the levels of liver functional enzymes including alanine aminotransferase (ALT) and glutamic-oxaloacetic transaminase (AST) in serum, while concentration of lactic acid concentration in blood plasma was decreased. VC-administered CCl4-lesioned mice manifested increased activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX), while the malondialdehyde (MDA) content was reduced in liver tissue. Moreover, VC consumption attenuated hepatotoxic injuries of CCl4-lesioned mice, in which the number of TNF-α positive cells was dose-dependently reduced. Furthermore, intrahepatic expression of TRL-4 mRNA, a vital inflammation-regulator, was down-regulated in VC-administered mice. Overall, we conclude that VC has the potentiality of anti-hepatotoxicity that is capable of ameliorating liver functions, speculating that therapeutic mechanism relates to normalizing metabolism and blocking inflammatory stress in the liver.
在病理上,肝损伤可由包括急性损伤在内的对肝细胞的持续创伤引起。因此,减轻肝细胞损伤可能有助于改善肝功能。本研究的目的是探讨摄入维生素C(VC)对四氯化碳(CCl4)暴露小鼠急性肝内损伤的潜在益处。我们的数据表明,补充VC有助于改善CCl4损伤小鼠的生命体征,导致肝肿大呈剂量依赖性减轻。VC降低了血清中包括丙氨酸转氨酶(ALT)和谷草转氨酶(AST)在内的肝功能酶水平,同时血浆中乳酸浓度降低。给予VC的CCl4损伤小鼠表现出超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-PX)活性增加,而肝组织中丙二醛(MDA)含量降低。此外,摄入VC减轻了CCl4损伤小鼠的肝毒性损伤,其中TNF-α阳性细胞数量呈剂量依赖性减少。此外,在给予VC的小鼠中,重要的炎症调节因子TRL-4 mRNA的肝内表达下调。总体而言,我们得出结论,VC具有抗肝毒性的潜力,能够改善肝功能,推测其治疗机制与肝脏代谢正常化和阻断炎症应激有关。